Skip to main content

Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update

Oversubscribed $30 million private placement closed, with proceeds expected to support ongoing development of APR-1051 Two partial responses observed with continued encouraging tolerability in the ongoing Phase 1 dose escalation ACESOT-1051 trial of WEE1 inhibitor APR-1051 Additional clinical data from ACESOT-1051 to be provided at the ASCO 2026 Annual Meeting on May 30, 2026 $46.5 million in cash and cash equivalents as of March 31, 2026, with anticipated cash runway into Q1 2028DOYLESTOWN, Pa., May 13, 2026 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage precision medicine oncology company focused on the discovery and development of targeted therapies for patients with biomarker-defined cancers, today reported financial results for the first quarter ended March 31, 2026,...

Continue reading

Skeena Gold & Silver Releases 2025 Sustainability Report Entitled ‘Where Voices Meet, Progress Follows’

VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) — Skeena Resources Limited (TSX: SKE, NYSE: SKE) (“Skeena Gold & Silver”, “Skeena” or the “Company”) today released its 2025 Sustainability Report, capturing a year of historic achievements and unparalleled collaboration with Indigenous partners that has set the stage for sustainable growth and success. All figures reported in this news release are in Canadian dollars. Randy Reichert, President & Chief Executive Officer of Skeena, commented, “2025 marked a transformative chapter for the Company made possible by the relentless work, dedication and collaborative spirit of our entire team. We achieved crucial milestones that strengthened our business, fortified our partnerships, progressed our sustainability commitments and propelled the Eskay Creek mine closer to...

Continue reading

TransUnion Declares First Quarter 2026 Dividend of $0.125 per Share

CHICAGO, May 13, 2026 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that its Board of Directors declared a cash dividend of $0.125 per share for the first quarter 2026. The dividend will be payable on June 11, 2026, to shareholders of record on May 27, 2026. About TransUnion (NYSE: TRU) TransUnion is a global information and insights company with over 13,000 associates operating in more than 30 countries. We make trust possible by ensuring each person is reliably represented in the marketplace. We do this with a Tru™ picture of each person: an actionable view of consumers, stewarded with care. Through our acquisitions and technology investments we have developed innovative solutions that extend beyond our strong foundation in core credit into areas such as marketing, fraud, risk and advanced analytics. As a result,...

Continue reading

Eos Energy Enterprises Reports First Quarter 2026 Financial Results and Announces Frontier Power USA

Announced with Cerberus the formation of Frontier Power USA, a stand-alone purpose-built entity to develop, finance, and operate LDES projects to accelerate energy storage deployments  Entered into a 2 GWh firm capacity reservation agreement with Frontier Power USA $57.0 million in quarterly revenue with the last two quarters surpassing full year 2025 revenue Achieved record quarterly production performance for shipments, battery output, and bipolar manufacturing Completed Factory Acceptance Testing for its second battery line with installation and power-on at the Thorn Hill facility underway; initial production is on schedule and expected to begin by the end of the second quarter Surpassed 6.0 GWh of discharged energy from Eos technology; DawnOS™ demonstrating consistent operating performance and improved round trip efficiency Expanded...

Continue reading

Equinox Gold and Orla Mining Combine to Create North America’s New Senior Gold Producer: Built to Grow, Built to Last

Combined company expected to produce 1.1 million ounces of gold annually with a clear path to more than 1.9 million ounces of gold from North American growth assets VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) — Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox”) and Orla Mining Ltd. (TSX: OLA, NYSE American: ORLA) (“Orla”, and together with Equinox, the “Companies”) are pleased to announce that the Companies have entered into a definitive arrangement agreement (the “Agreement”) for an at-market combination to create a new North American senior gold producer with approximately 1.1 million ouncesi of expected annual gold production and an $18.5 billion implied market capitalization. The combined company will be anchored by three long-life Canadian gold mines, with a clear path to more than 1.9 million ouncesii...

Continue reading

Costamare Bulkers Holdings Limited Reports Results For the First Quarter Ended March 31, 2026

MONACO, May 13, 2026 (GLOBE NEWSWIRE) — Costamare Bulkers Holdings Limited (“Costamare Bulkers” or the “Company”) (NYSE: CMDB) today reported unaudited financial results for the first quarter ended March 31, 2026 (“Q1 2026”). Financial Highlights1 and Operational Updates I. PROFITABILITY – LIQUIDITY – DEBTQ1 2026 Net Income of $9.9 million ($0.41 earnings per share). Q1 2026 Adjusted Net Income2 of $12.4 million ($0.51 earnings per share). Q1 2026 liquidity of $353.3 million3. Cash4 exceeding Debt5 by $127.2 million as of the end of Q1 2026.II. FLEET RENEWAL  Vessel AcquisitionConclusion of the purchase of the 2018-built, 60,297 DWT capacity dry bulk vessel, Astros (ex. Koushun)6.Long-term Charter-in AgreementsDelivery of the newbuild, 81,800 DWT capacity dry bulk vessel, Hermes Century:Minimum tenor...

Continue reading

Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update

– Obexelimab marketing applications for the treatment of IgG4-RD on-target for submission to the FDA this quarter and the EMA in H2 2026 based on the Phase 3 INDIGO IgG4-RD trial results – – Obexelimab Phase 3 INDIGO IgG4-RD trial results accepted for oral presentation at EULAR 2026 – – Obexelimab global Phase 2 SunStone SLE trial enrollment complete; topline results expected in Q4 2026 – – First subject dosed in Phase 1 trial of ZB021 (oral IL-17AA/AF inhibitor); initial clinical data expected by year-end – – Orelabrutinib global Phase 3 PriMroSe trial in patients with PPMS and global Phase 3 Monarch trial in patients with naSPMS ongoing – – Completed public offerings and entered into debt financing; cash runway extended into 2029 – WALTHAM, Mass., May 13, 2026 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma”...

Continue reading

Atour Lifestyle Holdings Limited Reports First Quarter 2026 Unaudited Financial Results

A total of 2,088 hotels, or 232,298 hotel rooms, in operation as of March 31, 2026. Net revenues for the first quarter of 2026 increased by 47.5% year-over-year to RMB2,811 million (US$408 million). Net income for the first quarter of 2026 increased by 90.3% year-over-year to RMB463 million (US$67 million). Adjusted net income (non-GAAP)1 for the first quarter of 2026 increased by 42.0% year-over-year to RMB490 million (US$71 million). EBITDA (non-GAAP)2 for the first quarter of 2026 increased by 85.2% year-over-year to RMB689 million (US$100 million). Adjusted EBITDA (non-GAAP)3 for the first quarter of 2026 increased by 51.1% year-over-year to RMB716 million (US$104 million).SHANGHAI, China, May 13, 2026 (GLOBE NEWSWIRE) — Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading lifestyle group...

Continue reading

ZRG Strengthens Education, Nonprofit & Social Impact Practice with Acquisition of Sterling Martin Associates

ROCHELLE PARK, N.J. and WASHINGTON, May 13, 2026 (GLOBE NEWSWIRE) — ZRG, the fastest-growing global talent advisory firm, today announced the acquisition of Sterling Martin Associates, a Washington, DC–based executive search firm specializing in professional associations, trade organizations, and mission-driven nonprofit organizations. The acquisition expands ZRG’s Education, Nonprofit & Social Impact (ENSI) practice and deepens its leadership advisory capabilities where governance, mission, and external stakeholders shape executive decision-making. Sterling Martin is recognized for a highly personalized, high-touch approach and deep credibility in the association space, advising organizations where leadership must balance industry influence with organizational stewardship.  Founded by David Martin in 2006, Sterling Martin...

Continue reading

NOTICE OF COMPULSORY ACQUISITION TO THE SHAREHOLDERS OF NILFISK HOLDING A/S PURSUANT TO SECTIONS 70-72 OF THE DANISH COMPANIES ACT

13 May 2026Freudenberg Home and Cleaning Solutions GmbH (“Freudenberg”) submitted, by way of an offer document published on 7 January 2026, as supplemented by a subsequent supplement of 19 February 2026, a recommended all-cash voluntary takeover offer (the “Offer”) to acquire all of the issued and outstanding shares (other than treasury shares) in Nilfisk Holding A/S (“Nilfisk”) at a price of DKK 140 per share (the “Offer price”). The offer period expired on 8 April 2026. On 15 April 2026, Freudenberg announced that the Offer had been completed as planned and on the same day notified Nilfisk that, following completion of the Offer, Freudenberg held a total ownership interest of 25,626,161 Nilfisk shares with a nominal value of DKK 20 each, corresponding to 94.47 per cent of the total share capital and the associated voting rights (excluding...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.